We are thrilled to be able to expand our market leading portfolio in the titanium interbody space. The addition of the Cervical Spine Truss System-Stand Alone product line not only broadens our current portfolio, but represents the first of many products to be released that will provide significant growth for the organization, said Jim Bruty, Sr. Vice President of Sales and Marketing. 4WEB will continue to provide clinicians with disruptive, clinically beneficial technology achieved through product development.
4WEB Medical's proprietary Truss Implant Technology utilizes the concept of mechanobiology to simulate cellular activity at the surgical site. The manufacturing process used to produce the implant's Advanced Structural Design creates a hierarchical surface roughness with features that span from the macro to nano scale. In-vitro testing has shown that stem cells attached to 4WEB's titanium implant surface exhibited increased gene expression of certain osteogenic markers when compared to smooth titanium and PEEK.
The company remains focused on accelerating growth over the next 5 years with investments in product development, procedural based solutions and clinical research.